Jean-Guy Baril

This researcher studies HIV (human immunodeficiency virus) treatment and prevention, focusing on how people living with HIV respond to antiretroviral therapy over the long term. Much of the work examines complications that arise despite well-controlled infection, such as cardiovascular disease, chronic inflammation, and immune system changes, as well as public-health strategies like pre-exposure prophylaxis (PrEP) to prevent new infections.

Publication activity has been fairly steady over the past decade, with a peak around 2022–2023 and a lower number of publications in the most recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Typically publishes in teams of ~14 · 3% small-team papers (≤3 authors) · across 20 venues